vs
Astrana Health, Inc.（ASTH）与Crane NXT, Co.（CXT）财务数据对比。点击上方公司名可切换其他公司
Astrana Health, Inc.的季度营收约是Crane NXT, Co.的2.5倍（$950.5M vs $387.7M），Crane NXT, Co.净利率更高（1.7% vs 0.7%，领先1.0%），Astrana Health, Inc.同比增速更快（42.9% vs 17.4%），Astrana Health, Inc.自由现金流更多（$-6.0M vs $-24.1M），过去两年Astrana Health, Inc.的营收复合增速更高（53.3% vs 2.3%）
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商，主要服务全美符合联邦医保资格的老年群体，提供上门初级护理、慢性病管理及护理协调服务，致力于提升患者健康水平、降低不必要的医疗支出。
Crane NXT是一家总部位于美国康涅狄格州斯坦福德的工业产品企业，由理查德·特勒·克莱恩于1855年创立。曾是美国头部卫浴配件制造商，1990年出售卫浴业务后，自1960年起逐步转型为多元化控股集团，目前核心业务涵盖航空航天与电子、工程材料、流体处理、控制设备四大板块，服务化工等多个行业领域。
ASTH vs CXT — 直观对比
营收规模更大
ASTH
是对方的2.5倍
$387.7M
营收增速更快
ASTH
高出25.5%
17.4%
净利率更高
CXT
高出1.0%
0.7%
自由现金流更多
ASTH
多$18.1M
$-24.1M
两年增速更快
ASTH
近两年复合增速
2.3%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $950.5M | $387.7M |
| 净利润 | $6.6M | $6.4M |
| 毛利率 | — | 40.2% |
| 营业利润率 | 1.9% | — |
| 净利率 | 0.7% | 1.7% |
| 营收同比 | 42.9% | 17.4% |
| 净利润同比 | 184.4% | -70.5% |
| 每股收益（稀释后） | $0.12 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASTHCXT
| Q1 26 | — | $387.7M | ||
| Q4 25 | $950.5M | $476.9M | ||
| Q3 25 | $956.0M | $445.1M | ||
| Q2 25 | $654.8M | $404.4M | ||
| Q1 25 | $620.4M | $330.3M | ||
| Q4 24 | $665.2M | $399.1M | ||
| Q3 24 | $478.7M | $403.5M | ||
| Q2 24 | $486.3M | $370.6M |
净利润ASTHCXT
| Q1 26 | — | $6.4M | ||
| Q4 25 | $6.6M | $47.5M | ||
| Q3 25 | $373.0K | $50.5M | ||
| Q2 25 | $9.4M | $24.9M | ||
| Q1 25 | $6.7M | $21.7M | ||
| Q4 24 | $-7.8M | — | ||
| Q3 24 | $16.1M | $47.1M | ||
| Q2 24 | $19.2M | $41.6M |
毛利率ASTHCXT
| Q1 26 | — | 40.2% | ||
| Q4 25 | — | 42.4% | ||
| Q3 25 | — | 43.3% | ||
| Q2 25 | — | 41.7% | ||
| Q1 25 | — | 42.4% | ||
| Q4 24 | — | 45.2% | ||
| Q3 24 | — | 42.5% | ||
| Q2 24 | — | 43.4% |
营业利润率ASTHCXT
| Q1 26 | — | — | ||
| Q4 25 | 1.9% | 16.7% | ||
| Q3 25 | 2.0% | 18.4% | ||
| Q2 25 | 3.1% | 11.8% | ||
| Q1 25 | 3.3% | 11.3% | ||
| Q4 24 | 0.1% | 17.7% | ||
| Q3 24 | 5.9% | 18.6% | ||
| Q2 24 | 6.2% | 18.2% |
净利率ASTHCXT
| Q1 26 | — | 1.7% | ||
| Q4 25 | 0.7% | 10.0% | ||
| Q3 25 | 0.0% | 11.3% | ||
| Q2 25 | 1.4% | 6.2% | ||
| Q1 25 | 1.1% | 6.6% | ||
| Q4 24 | -1.2% | — | ||
| Q3 24 | 3.4% | 11.7% | ||
| Q2 24 | 3.9% | 11.2% |
每股收益（稀释后）ASTHCXT
| Q1 26 | — | — | ||
| Q4 25 | $0.12 | $0.82 | ||
| Q3 25 | $0.01 | $0.87 | ||
| Q2 25 | $0.19 | $0.43 | ||
| Q1 25 | $0.14 | $0.38 | ||
| Q4 24 | $-0.14 | $1.00 | ||
| Q3 24 | $0.33 | $0.81 | ||
| Q2 24 | $0.40 | $0.72 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | $228.3M |
| 总债务越低越好 | — | $1.5B |
| 股东权益账面价值 | $779.3M | $1.2B |
| 总资产 | $2.2B | $3.6B |
| 负债/权益比越低杠杆越低 | — | 1.22× |
8季度趋势，按日历期对齐
现金及短期投资ASTHCXT
| Q1 26 | — | $228.3M | ||
| Q4 25 | $429.5M | $233.8M | ||
| Q3 25 | $463.4M | $182.4M | ||
| Q2 25 | $342.1M | $152.5M | ||
| Q1 25 | $260.9M | $173.8M | ||
| Q4 24 | $290.8M | $165.8M | ||
| Q3 24 | $350.3M | $165.1M | ||
| Q2 24 | $327.7M | $175.5M |
总债务ASTHCXT
| Q1 26 | — | $1.5B | ||
| Q4 25 | — | $1.0B | ||
| Q3 25 | — | $834.3M | ||
| Q2 25 | — | $861.8M | ||
| Q1 25 | — | $541.1M | ||
| Q4 24 | — | $540.6M | ||
| Q3 24 | — | $638.2M | ||
| Q2 24 | — | $638.9M |
股东权益ASTHCXT
| Q1 26 | — | $1.2B | ||
| Q4 25 | $779.3M | $1.3B | ||
| Q3 25 | $775.5M | $1.2B | ||
| Q2 25 | $765.5M | $1.2B | ||
| Q1 25 | $745.4M | $1.1B | ||
| Q4 24 | $712.7M | $1.1B | ||
| Q3 24 | $704.6M | $1.1B | ||
| Q2 24 | $678.9M | $989.8M |
总资产ASTHCXT
| Q1 26 | — | $3.6B | ||
| Q4 25 | $2.2B | $3.1B | ||
| Q3 25 | $2.2B | $2.9B | ||
| Q2 25 | $1.4B | $2.9B | ||
| Q1 25 | $1.3B | $2.4B | ||
| Q4 24 | $1.4B | $2.4B | ||
| Q3 24 | $1.3B | $2.4B | ||
| Q2 24 | $1.3B | $2.4B |
负债/权益比ASTHCXT
| Q1 26 | — | 1.22× | ||
| Q4 25 | — | 0.80× | ||
| Q3 25 | — | 0.69× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 0.49× | ||
| Q4 24 | — | 0.51× | ||
| Q3 24 | — | 0.60× | ||
| Q2 24 | — | 0.65× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.9M | — |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | $-24.1M |
| 自由现金流率自由现金流/营收 | -0.6% | -6.2% |
| 资本支出强度资本支出/营收 | 0.3% | 2.6% |
| 现金转化率经营现金流/净利润 | -0.44× | — |
| 过去12个月自由现金流最近4个季度 | $104.5M | — |
8季度趋势，按日历期对齐
经营现金流ASTHCXT
| Q1 26 | — | — | ||
| Q4 25 | $-2.9M | $105.8M | ||
| Q3 25 | $10.0M | $92.0M | ||
| Q2 25 | $90.9M | $62.8M | ||
| Q1 25 | $16.6M | $-19.1M | ||
| Q4 24 | $-10.9M | $81.1M | ||
| Q3 24 | $34.0M | $66.7M | ||
| Q2 24 | $23.2M | $56.8M |
自由现金流ASTHCXT
| Q1 26 | — | $-24.1M | ||
| Q4 25 | $-6.0M | — | ||
| Q3 25 | $7.4M | $78.7M | ||
| Q2 25 | $89.5M | $55.8M | ||
| Q1 25 | $13.6M | $-32.2M | ||
| Q4 24 | $-13.5M | — | ||
| Q3 24 | $31.7M | $53.5M | ||
| Q2 24 | $20.4M | $47.9M |
自由现金流率ASTHCXT
| Q1 26 | — | -6.2% | ||
| Q4 25 | -0.6% | — | ||
| Q3 25 | 0.8% | 17.7% | ||
| Q2 25 | 13.7% | 13.8% | ||
| Q1 25 | 2.2% | -9.7% | ||
| Q4 24 | -2.0% | — | ||
| Q3 24 | 6.6% | 13.3% | ||
| Q2 24 | 4.2% | 12.9% |
资本支出强度ASTHCXT
| Q1 26 | — | 2.6% | ||
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.3% | 3.0% | ||
| Q2 25 | 0.2% | 1.7% | ||
| Q1 25 | 0.5% | 4.0% | ||
| Q4 24 | 0.4% | — | ||
| Q3 24 | 0.5% | 3.3% | ||
| Q2 24 | 0.6% | 2.4% |
现金转化率ASTHCXT
| Q1 26 | — | — | ||
| Q4 25 | -0.44× | 2.23× | ||
| Q3 25 | 26.69× | 1.82× | ||
| Q2 25 | 9.65× | 2.52× | ||
| Q1 25 | 2.48× | -0.88× | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.11× | 1.42× | ||
| Q2 24 | 1.21× | 1.37× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
CXT
| Detection and Traceability Technologies | $194.9M | 50% |
| Security and Authentication Technologies | $192.8M | 50% |
